Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis
Article in Scientific Reports (May 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in Scientific Reports (May 2024)
Article in Biomolecules & Therapeutics (April 2024)
Article in Frontiers in Cellular Neuroscience (March 2024)